104 related articles for article (PubMed ID: 20368544)
1. Active surveillance in young patients with prostate cancer: the unanswered question.
Campodonico F; Maffezzini M
J Clin Oncol; 2010 May; 28(13):e211; author reply e212. PubMed ID: 20368544
[No Abstract] [Full Text] [Related]
2. Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen P
Eur Urol; 2010 Dec; 58(6):836-7. PubMed ID: 20851512
[No Abstract] [Full Text] [Related]
3. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
Aus G
Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
[No Abstract] [Full Text] [Related]
4. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
Albertson PC
Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
[No Abstract] [Full Text] [Related]
5. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
6. A rational approach to prostate cancer.
Kirk D
Practitioner; 2000 Sep; 244(1614):750, 754-6, 758 passim. PubMed ID: 11048371
[No Abstract] [Full Text] [Related]
7. Active surveillance for the management of prostate cancer in a contemporary cohort.
Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
[TBL] [Abstract][Full Text] [Related]
8. Early prostate cancer diagnosis and therapy.
Glodé LM
Adv Intern Med; 2000; 45():41-64. PubMed ID: 10635045
[No Abstract] [Full Text] [Related]
9. Expectant treatment with curative intent in the prostate-specific antigen era: triggers for definitive therapy.
Warlick CA; Allaf ME; Carter HB
Urol Oncol; 2006; 24(1):51-7. PubMed ID: 16414495
[TBL] [Abstract][Full Text] [Related]
10. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
Kantoff PW; Talcott JA
Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience.
Soloway MS; Soloway CT; Williams S; Ayyathurai R; Kava B; Manoharan M
BJU Int; 2008 Jan; 101(2):165-9. PubMed ID: 17850361
[TBL] [Abstract][Full Text] [Related]
12. [Prostatic cancer before the age of 50--report of 7 cases].
Aubert J; Dore B; Irani J; Aubert MN
Prog Urol; 1991 Jun; 1(3):432-9. PubMed ID: 1726944
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance with selective delayed intervention for favorable risk prostate cancer.
Klotz L
Urol Oncol; 2006; 24(1):46-50. PubMed ID: 16414494
[TBL] [Abstract][Full Text] [Related]
14. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
Hegarty JM; Wallace M; Comber H
Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
Ercole B; Marietti SR; Fine J; Albertsen PC
J Urol; 2008 Oct; 180(4):1336-9; discussion 1340-1. PubMed ID: 18707696
[TBL] [Abstract][Full Text] [Related]
16. A guideline to clinical utility of prostate specific antigen.
Farhat WA; Habbal AA; Khauli RB
Saudi Med J; 2000 Mar; 21(3):223-7. PubMed ID: 11533789
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen velocity in untreated, localized prostate cancer.
Venkitaraman R; Norman A; Woode-Amissah R; Dearnaley D; Horwich A; Huddart R; Parker C
BJU Int; 2008 Jan; 101(2):161-4. PubMed ID: 17850368
[TBL] [Abstract][Full Text] [Related]
18. Integrative tumor board: recently diagnosed prostate cancer.
Schacht MJ; Saxe GA; Bauer-Wu S; Kennedy S; Monti DA; Peterson C; Rosenberg Z; Block KI
Integr Cancer Ther; 2003 Mar; 2(1):63-90. PubMed ID: 12941168
[No Abstract] [Full Text] [Related]
19. [Cancer of the prostate. Diagnosis, prognosis, principles of treatment].
Lopez JG; Perrin P
Rev Prat; 1999 Feb; 49(3):297-301. PubMed ID: 10189800
[No Abstract] [Full Text] [Related]
20. The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment.
Gjengstø P; Eide J; Frugård J; Bakke A; Høisaeter PA
Scand J Urol Nephrol; 2004; 38(1):15-8. PubMed ID: 15204421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
